Going Global: Should You Take the Leap?
Before moving into the global market, a company needs to understand the local structure of geographic regions.
Before moving into the global market, a company needs to understand the local structure of geographic regions.
Johnson & Johnson holds firm that it will continue to accelerate in the innovation department over the next year.
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.
Acquisitions and joint ventures with Asian medical companies can provide many advantages for Western firms looking to grow their businesses in Asian medical device markets.
Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.
Cardinal CEO George Barrett has said that the company may make more acquisitions in cardiology and endovascular treatment as well as in the trauma and wound care segment.
There are great opportunities for foreign medical device companies in China as the people want better healthcare, the government is increasing access to healthcare, and the market is growing between 15 and 20 percent per year. But access to the marketplace is harder than ever. Why?
Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.
The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.